Jennifer Swettenham

1 presentation

• T61. THE USE OF MAGNETOENCEPHALOGRAPHY (MEG) IN A FIRST-IN-HUMAN TRIAL TO DEMONSTRATE THE FUNCTIONAL CONSEQUENCES OF TARGET ENGAGEMENT BY DT-101, A NOVEL AMPA RECEPTOR POSITIVE ALLOSTERIC MODULATOR

  2026 ASCP Annual Meeting